Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis

Overview of attention for article published in Cochrane database of systematic reviews, January 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 4 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 268 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 33 publications that cite this research output.

33

The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.

Extended stop codon context predicts nonsense codon readthrough efficiency in human cells

Article in Nature Communications (March 2024)

A Chinese pediatric cystic fibrosis patient with the c.1624G>T, p. Gly542x/c.223C>T, p. Arg75x genotype

Article in Pediatric Pulmonology (September 2023)

Ataluren prevented bone loss induced by ovariectomy and aging in mice through the BMP-SMAD signaling pathway

Article in Biomedicine & Pharmacotherapy (August 2023)